• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Hemab Therapeutics Presents Positive Phase 1 Results for HMB-001

    PR NEWSWIRE

    Hemab Announces First Patient Dosed in Phase 2 Study Investigating HMB-001

    PR NEWSWIRE

    Hemab Therapeutics Presents New Preclinical Research Demonstrating Effects

    PR NEWSWIRE

    Hemab Therapeutics to Present New Preclinical Data on HMB-001

    PR NEWSWIRE

    Hemab uses $135M series B to target neglected blood disorders

    FIERCE BIOTECH

    Rare blood disorders biotech Hemab raises $135M, begins trek into clinic

    ENDPTS

    Hemab doses first patient in Phase I/II trial of antibody for Glanzmann

    CLINICALTRIALSARENA

    Hemab presents positive preclinical data on HMB-001 at EAHAD 2022 congress

    PHARMABIZ

    Hemab Tx`s HMB-001 with Potential for Treatment of Rare Bleeding Disorders

    PRNEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.